Nagisa Nakata

Title: The Innovations of Nagisa Nakata

Introduction

Nagisa Nakata is a prominent inventor based in Gosen, Japan. She has made significant contributions to the field of vaccine development, particularly in the area of influenza vaccines. With a total of 2 patents, her work has the potential to enhance public health and safety.

Latest Patents

Nakata's latest patents include an inactivated whole-virus influenza vaccine and a method for preparing the same. This innovative vaccine aims to maintain or enhance its antibody-inducing ability while causing fewer side reactions. The preparation method utilizes an embryonated chicken egg method, which involves subjecting a virus solution containing a whole influenza virus collected from embryonated chicken eggs to a hypotonic treatment. Additionally, she has developed a mucosal adjuvant that exhibits high mucosal immunogenicity and safety, making it useful in the preparation of mucosal vaccines. This mucosal vaccine composition may include TGDK, and the preparation method involves mixing TGDK with an immunogen.

Career Highlights

Throughout her career, Nakata has worked with notable organizations such as Denka Company Limited and Kumamoto University. Her experience in these institutions has allowed her to advance her research and contribute to significant innovations in vaccine technology.

Collaborations

Nakata has collaborated with several professionals in her field, including Ryotaro Mitsumata and Shogo Misumi. These collaborations have further enriched her research and development efforts.

Conclusion

Nagisa Nakata's contributions to vaccine innovation are noteworthy and reflect her dedication to improving public health. Her patents and collaborations highlight her role as a leading inventor in the field of immunology.